1.61 USD
▼-0.08-4.73%
盘后 1.64 0.00%
2026-11-19
市值
$1.17B
市盈率
—
EPS
-0.20
股息率
—
52 周区间
0.98 – 1.86
成交量
2.13M
Beta
1.53
目标价
4.15
52W 低 0.9852W 高 1.86
价格走势
公司简介
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune syst...